TITLE

Endo Makes a Pickup

AUTHOR(S)
Marino, Jonathan
PUB. DATE
May 2010
SOURCE
Mergers & Acquisitions Report;5/10/2010, Vol. 23 Issue 19, p27
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the decision of Endo Pharmaceuticals to buy HealthTronics, a listed, Texan provider of urological products and services, in a 223 million dollar deal.
ACCESSION #
50449285

 

Related Articles

  • Court report.  // Medical Device Daily;5/10/2010, Vol. 14 Issue 89, p9 

    This article reports on the plan of the law offices of Howard G. Smith to investigate potential claims against the board of HealthTronics concerning its agreement to be acquired by Endo Pharmaceuticals.

  • Endo completes tender offer in $223M HealthTronics buy.  // Medical Device Daily;7/6/2010, Vol. 14 Issue 129, p3 

    The article reports on the completion of the tender offer for all of the outstanding shares of common stock of HealthTronics by Endo Pharmaceuticals in July 2010.

  • Deals roundup.  // Medical Device Daily;7/14/2010, Vol. 14 Issue 135, p10 

    The article reports that the subsequent offering period of the tender offer by Endo Pharmaceuticals' wholly owned subsidiary HT Acquisition Corp. for all of the outstanding shares of common stock of HealthTronics has expired.

  • Endo Offering $700M in HY for M&A. Sheahan, Matthew // High Yield Report;5/30/2011, Vol. 22 Issue 22, p17 

    The article focuses on a junk bond offering from Endo Pharmaceuticals which intends to support an acquisition deal.

  • General News.  // PharmaWatch: CNS;Feb2009, Vol. 8 Issue 2, p19 

    The article offers news briefs related to pharmaceutical industry. The Endo Pharmaceuticals Inc. and the Indevus Pharmaceuticals Inc. have merged for $370 million Indevus shares. The Copernicus Therapeutics Inc. and the University of Kentucky declared a collaboration to create a DNA nanoparticle...

  • Endo Makes a Play in the Generics Market.  // Pharmaceutical Representative;Nov2010, Vol. 40 Issue 11, p7 

    The article offers updates on several pharmaceutical companies in the U.S. It includes Endo Pharmaceuticals Inc., Pfizer Inc. and Aegerion Pharmaceuticals Inc. It notes that Endo Pharmaceuticals Inc. has acquired the privately held company Quality Pharmaceuticals Inc. for about 1.2 billion...

  • Endo to Acquire Penwest for $168M, Cutting Royalty Stream. Hollingsworth, Catherine // BioWorld Today;8/11/2010, Vol. 21 Issue 154, p1 

    The article discusses the acquisition by Endo Pharmaceuticals Inc. of all the common stock of Penwest Pharmaceuticals Co. worth 168 million U.S. dollars in total equity value. Endo and Penwest have worked together since 1997 in developing and commercializing Opana ER, a drug for pain management....

  • The Industry.  // Pharmaceutical Representative;Mar2009, Vol. 39 Issue 3, p10 

    The article offers news briefs related to pharmaceutical industry. Endo Pharmaceuticals Inc. has bought outstanding shares of Indevus Pharmaceuticals Inc. for almost $370 million, in addition to $267 million in potential regulatory. GlaxoSmithKline is acquiring UCB's products and commercial...

  • Changing partnership models reflect new paths to business. Stommen, Jim // Medical Device Daily;5/15/2012, Vol. 16 Issue 94, p1 

    The article deals with the goals of Endo Pharmaceuticals in the medical device sector, as explained by Julie McHugh, chief operating officer of the firm, during the 11th annual MedTech Investing Conference in May 2012. She reveals that the firm made a number of acquisitions to shore up Endo's...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics